Shana Traina

1.9k total citations
24 papers, 1.1k citations indexed

About

Shana Traina is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Rheumatology. According to data from OpenAlex, Shana Traina has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Rheumatology. Recurrent topics in Shana Traina's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Diabetes Management and Education (4 papers). Shana Traina is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Diabetes Management and Education (4 papers). Shana Traina collaborates with scholars based in United States, Canada and United Kingdom. Shana Traina's co-authors include Catherine H. MacLean, David Cella, Hema N. Viswanathan, Eric P. Elkin, David H. Henry, Walter Mojica, Amalia M. Issa, Sally C. Morton, Sydne J Newberry and Rena Hasenfeld Garland and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Shana Traina

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shana Traina United States	14	261	250	221	212	185	24	1.1k
Stephanie A. Navarro Silvera United States	21	215 0.8×	414 1.7×	140 0.6×	272 1.3×	202 1.1×	29	1.3k
Norma McFarlane‐Anderson Jamaica	22	202 0.8×	148 0.6×	302 1.4×	219 1.0×	103 0.6×	54	1.5k
Yong-Bing Xiang United States	20	171 0.7×	130 0.5×	116 0.5×	249 1.2×	117 0.6×	33	1.2k
M. Vinayaga Moorthy United States	26	177 0.7×	144 0.6×	253 1.1×	274 1.3×	310 1.7×	46	1.9k
Chonghua Yao China	12	188 0.7×	90 0.4×	342 1.5×	406 1.9×	182 1.0×	34	2.0k
Lyanne M. Kieneker Netherlands	23	197 0.8×	105 0.4×	216 1.0×	172 0.8×	155 0.8×	66	1.5k
G. Berglund Sweden	21	150 0.6×	206 0.8×	346 1.6×	398 1.9×	245 1.3×	31	1.7k
Paulette D. Chandler United States	16	275 1.1×	154 0.6×	86 0.4×	250 1.2×	88 0.5×	37	1.2k
Scott R. Bauer United States	16	121 0.5×	228 0.9×	121 0.5×	184 0.9×	214 1.2×	54	1.3k
Fumio Sakauchi Japan	19	99 0.4×	437 1.7×	121 0.5×	236 1.1×	170 0.9×	42	1.5k

Countries citing papers authored by Shana Traina

Since Specialization

Citations

This map shows the geographic impact of Shana Traina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shana Traina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shana Traina more than expected).

Fields of papers citing papers by Shana Traina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shana Traina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shana Traina. The network helps show where Shana Traina may publish in the future.

Co-authorship network of co-authors of Shana Traina

This figure shows the co-authorship network connecting the top 25 collaborators of Shana Traina. A scholar is included among the top collaborators of Shana Traina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shana Traina. Shana Traina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willis, Michael, et al.. (2020). Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model. Diabetes Therapy. 12(1). 313–328. 29 indexed citations

Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2019). CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice. Canadian Journal of Diabetes. 43(7). 464–471. 4 indexed citations

Fastenau, John, Ronette L. Kolotkin, Ken Fujioka, et al.. (2019). A call to action to inform patient‐centred approaches to obesity management: Development of a disease‐illness model. Clinical Obesity. 9(3). e12309–e12309. 43 indexed citations

Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2018). CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice. Diabetes Obesity and Metabolism. 21(3). 691–699. 9 indexed citations

Cai, Jennifer, Linda M. Delahanty, Sydney Akapame, April Slee, & Shana Traina. (2018). Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials. Patient. 11(3). 341–352. 9 indexed citations

Traina, Shana, April Slee, Suzy Van Sanden, & Joris Diels. (2017). An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin. Diabetes Therapy. 9(1). 125–140.

Heß, Georg, Simon Rule, Wojciech Jurczak, et al.. (2017). Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Leukemia & lymphoma. 58(12). 2824–2832. 15 indexed citations

Traina, Shana, Susan D. Mathias, Hilary H. Colwell, Ross D. Crosby, & Charles Abraham. (2016). The Diabetes Intention, Attitude, and Behavior Questionnaire: evaluation of a brief questionnaire to measure physical activity, dietary control, maintenance of a healthy weight, and psychological antecedents. Patient Preference and Adherence. 10. 213–213. 16 indexed citations

Rodbard, Helena W., et al.. (2016). The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes. Diabetes Care. 40(2). 171–180. 80 indexed citations

10.

Traina, Shana, et al.. (2016). Analysis of the temporal relationship between patient-reported outcomes (PROs) and overall survival (OS) and radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).. Journal of Clinical Oncology. 34(2_suppl). 240–240. 2 indexed citations

11.

Traina, Shana, Hilary H. Colwell, Ross D. Crosby, & Susan D. Mathias. (2015). Pragmatic measurement of health satisfaction in people with type 2 diabetes mellitus using the Current Health Satisfaction Questionnaire. Patient Related Outcome Measures. 6. 103–103. 17 indexed citations

12.

Traina, Shana, April Slee, Sangsoon Woo, & William Canovatchel. (2015). The Importance of Weight Change Experiences for Performance of Diabetes Self-Care: A Patient-Centered Approach to Evaluating Clinical Outcomes in Type 2 Diabetes. Diabetes Therapy. 6(4). 611–625. 10 indexed citations

13.

Traina, Shana, Robert Guthrie, & April Slee. (2014). The Impact of Weight Loss on Weight-related Quality of Life and Health Satisfaction: Results From a Trial Comparing Canagliflozin With Sitagliptin in Triple Therapy Among People With Type 2 Diabetes. Postgraduate Medicine. 126(3). 7–15. 26 indexed citations

14.

Henry, David H., et al.. (2008). Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.. Supportive Care in Cancer. 16(7). 791–801. 283 indexed citations

15.

Boonen, Annelies, et al.. (2008). Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.. PubMed. 35(4). 662–7. 31 indexed citations

16.

MacLean, Catherine H., Sydne J Newberry, Walter Mojica, et al.. (2006). Effects of Omega-3 Fatty Acids on Cancer Risk. JAMA. 295(4). 403–403. 366 indexed citations

17.

Kahn, Katherine L., Catherine H. MacLean, Laurence Z. Rubenstein, et al.. (2006). The Complexity of Care for Patients with Rheumatoid Arthritis. Medical Care. 45(1). 55–65. 5 indexed citations

18.

Khanna, Dinesh, Erin L. Arnold, James Pencharz, et al.. (2006). Measuring Process of Arthritis Care: The Arthritis Foundation’s Quality Indicator Set for Rheumatoid Arthritis. Seminars in Arthritis and Rheumatism. 35(4). 211–237. 36 indexed citations

19.

Issa, Amalia M., Walter Mojica, Sally C. Morton, et al.. (2005). The Efficacy of Omega–3 Fatty Acids on Cognitive Function in Aging and Dementia: A Systematic Review. Dementia and Geriatric Cognitive Disorders. 21(2). 88–96. 71 indexed citations

20.

Traina, Shana, Catherine H. MacLean, Grace S. Park, & Katherine L. Kahn. (2005). Telephone reminder calls increased response rates to mailed study consent forms. Journal of Clinical Epidemiology. 58(7). 743–746. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact